Trial Profile
Cyclic PDT for the Prevention of Actinic Keratosis and Non Melanoma Skin Cancer in Solid Organ Transplant Recipients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 18 Mar 2024
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis; Carcinoma; Skin cancer
- Focus Therapeutic Use
- 12 Mar 2024 Status changed from recruiting to completed.
- 03 May 2021 Planned End Date changed from 30 Apr 2021 to 1 Jan 2022.
- 03 May 2021 Planned primary completion date changed from 30 Apr 2020 to 1 Jan 2022.